Ocugen

OCGNNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$434.061 M

$1.28 +3.23%

Close of 7 Aug 2026

Revenue

$4.41M

#3329 by revenue

Earnings

-$68.0M

Loss-making

Shares outstanding

339,110,401

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#73Editas MedicineEDIT$442.3M
#74X4 PharmaceuticalsXFOR$437.6M
#75OcugenOCGN$434.1M
#76Scribe TherapeuticsSCTX$420.7M
#77Sutro BiopharmaSTRO$420.6M

Where these numbers come from

Share counts and financials for Ocugen are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.